Log In
Print
BCIQ
Print
Print this Print this
 

Apligraf (formerly CelTx, Graftskin)

  Manage Alerts
Collapse Summary General Information
Company Organogenesis Inc.
DescriptionGraftskin engineered tissue with layers of keratinocytes and fibroblasts
Molecular Target Not available
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentMarketed
Standard IndicationDermal ulcers
Indication DetailsTreat chronic venous ulcers; Treat decubitus ulcers (pressure sores); Treat diabetic foot ulcers; Treat diabetic foot ulcers and venous leg ulcers; Treat venous leg ulcers; Treat venous stasis ulcers
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today